Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
George Tsirakis
Observed names:
G Tsirakis,
G. TSIRAKIS,
G. Tsirakis,
George E. Tsirakis,
Georgios Tsirakis
Institution:
Chania General Hospital ”St. George”
Observed institutions:
University of Crete,
University Hospital of Larissa,
Chania General Hospital ”St. George”,
University Hospital of Heraklion
ORCID:
0000-0003-4286-3413
Observed ORCID:
0000-0003-4286-3413
OpenAlex ID:
A5037393777
Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma
2015
·
Michael G. Alexandrakis
, Nektaria Goulidaki
, et al.
·
Pathology & Oncology Research
·
61
Anemia in Heart Failure Patients
2012
·
Michael G. Alexandrakis
, George Tsirakis
·
ISRN Hematology
·
51
PDF
Role of platelet‐derived growth factor‐AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma
2011
·
George Tsirakis
, Constantina A. Pappa
, et al.
·
Hematological Oncology
·
41
Histological expression of angiogenic factors: VEGF, PDGFRα, and HIF-1α in Hodgkin lymphoma
2008
·
Freda H. Passam
, Michael G. Alexandrakis
, et al.
·
Pathology - Research and Practice
·
41
Serum levels of Interleukin-15 and Interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma
2007
·
C. Pappa
, S. Miyakis
, et al.
·
Cytokine
·
38
Serum Evaluation of Angiogenic Cytokines Basic Fibroblast Growth Factor, Hepatocyte Growth Factor and TNF-ALPHA in Patients with Myelodysplastic Syndromes: Correlation with Bone Marrow Microvascular Density
2005
·
M.G. Alexandrakis
, F.H. Passam
, et al.
·
International Journal of Immunopathology and Pharmacology
·
37
PDF
Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes
2004
·
Michael G. Alexandrakis
, Freda H. Passam
, et al.
·
Leukemia Research
·
35
Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma
2012
·
M. Fragioudaki
, G. Tsirakis
, et al.
·
Leukemia Research
·
34
Serum Levels of Leptin in Multiple Myeloma Patients and Its Relation to Angiogenic and Inflammatory Cytokines
2004
·
M.G. Alexandrakis
, F.H. Passam
, et al.
·
The International Journal of Biological Markers
·
32
B cell-activating factor: its clinical significance in multiple myeloma patients
2012
·
M. Fragioudaki
, A. Boula
, et al.
·
Annals of Hematology
·
29
Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma
2011
·
Aikaterini Sfiridaki
, Spiros Miyakis
, et al.
·
Journal of Hematology & Oncology
·
29
PDF
The Impact of Mast Cell Density on the Progression of Bone Disease in Multiple Myeloma Patients
2015
·
Rodanthi Vyzoukaki
, George Tsirakis
, et al.
·
International Archives of Allergy and Immunology
·
25
Relationship between Circulating BAFF Serum Levels with Proliferating Markers in Patients with Multiple Myeloma
2013
·
Michael G. Alexandrakis
, Parascevi Roussou
, et al.
·
BioMed Research International
·
25
PDF
Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma
2011
·
C.A. Pappa
, G. Tsirakis
, et al.
·
Cytokine
·
24
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease
2005
·
Aikaterini Sfiridaki
, Spiros Miyakis
, et al.
·
Clinical Chemistry and Laboratory Medicine (CCLM)
·
24
Assessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patients
2011
·
G. Tsirakis
, C. A. Pappa
, et al.
·
European Journal of Histochemistry
·
23
PDF
Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment
2011
·
K. Sfiridaki
, C. A. Pappa
, et al.
·
Mediators of Inflammation
·
22
PDF
Expression of the proliferation-associated nuclear protein MIB-1 and its relationship with microvascular density in bone marrow biopsies of patients with myelodysplastic syndromes
2004
·
Michael G Alexandrakis
, Freda H Passam
, et al.
·
The Histochemical Journal
·
18
Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma
2012
·
G. Tsirakis
, C.A. Pappa
, et al.
·
European Journal of Internal Medicine
·
17
Prognostic impact of angiopoietin-2 in multiple myeloma
2014
·
Constantina A. Pappa
, Michael G. Alexandrakis
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
15
Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma
2013
·
Constantina A Pappa
, George Tsirakis
, et al.
·
Cancer Investigation
·
15
Increased serum levels of MIP-1alpha correlate with bone disease and angiogenic cytokines in patients with multiple myeloma
2013
·
George Tsirakis
, Parascevi Roussou
, et al.
·
Medical Oncology
·
14
Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients
2013
·
CA Pappa
, MG Alexandrakis
, et al.
·
Hematological Oncology
·
14
Miliary tuberculosis with no pulmonary involvement in myelodysplastic syndromes: a curable, yet rarely diagnosed, disease: case report and review of the literature
2008
·
Ioannis K Neonakis
, Michael G Alexandrakis
, et al.
·
Annals of Clinical Microbiology and Antimicrobials
·
14
PDF
Clinical significance of interleukin-22 in multiple myeloma
2014
·
George Tsirakis
, Constantina A. Pappa
, et al.
·
Hematology
·
12
PDF
Show more works
View as search
Works count:
50
Citation count:
818
H-index:
18
I10-index:
31
Year
Topic
Type
